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Abstract
OBJECTIVE: To ascertain if total flavonoids of
Guangzao (Fructus Choerospondiatis) (TFFC) extract-
ed from Guangzao (Fructus Choerospondiatis) can
inhibit angiotensin Ⅱ-induced proliferation of car-
diac fibroblasts (CFs).
METHODS: CFs were cultured by the differential at-
tachment method. A model of cell proliferation was
established by stimulation with Ang Ⅱ. Cardiac fi-
broblasts growth was determined using a hemocy-
tometer. Cell proliferation was detected by methyl
thiazole tetrazolium. Lactate dehydrogenase activi-
tywas measured by chemical colorimetric method.
RESULTS: Proliferation of TFFC-treated (25, 50,
100 mg/L) fibroblasts was significantly less than
that of cells in the angiotensinⅡ group (P < 0.01),
and TFFC inhibited proliferation in a dose-depen-
dent manner. These inhibitory effects were partly
blocked by pretreatment with NG-nitro-L-arginine
methyl ester (L-NAME) and 1H-[1,2,4]-oxadiazole-
[4,3-a]-quinoxalin-1-one (ODQ).
CONCLUSION: TFFC inhibited angiotensin Ⅱ-in-
duced proliferation of cardiac fibroblasts via a
mechanism that probably involves activation of the
NO-cyclic guanosine monophosphate signaling
pathway.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Proliferation of cardiac fibroblasts and accumulation of
excessive amounts of proteins in the extracellular ma-
trix are the basic pathologic processes of myocardial fi-
brosis. Angiotensin Ⅱ (Ang Ⅱ) is considered to be an
important factor in the autocrine and paracrine func-
tions of cardiac fibroblasts.1,2 Furth0ermore, AngⅡ ac-
tivates a series of signaling molecules to induce cardiac
fibrosis.
Guangzao (Fructus Choerospondiatis) is a Chinese herb
believed to have therapeutic potential against cardiovas-
cular diseases.3 The main component extracted from
this herb, total flavonoids of Guangzao (Fructus Choero-
spondiatis) (TFFC), has been reported to have cardio-
protective effects.4 Thus, TFFC could be a therapeutic
agent for a multitude of cardiovascular diseases. Here,
we investigated if TFFC can inhibit Ang Ⅱ-induced
proliferation of cardiac fibroblasts.
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MATERIALS ANDMETHODS
This study was conducted in accordance with the insti-
tutional guidelines for the care and use of laboratory
animals set by Zhejiang University (Zhejiang, China).
Ethical approval was given by the Medical Ethics Com-
mittee of Zhejiang University.
Animals and reagents
Six male 3-day-old Sprague-Dawley (SD) rats were pur-
chased from the Laboratory Animal Center of Zheji-
ang University. L-NG-Nitroarginine methyl ester
(L-NAME), 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphen-
yltetrazolium bromide (MTT), 1H-[1,2,4] oxadiazolo
[4,3-a] quinoxalin-1-one (ODQ), and Ang Ⅱ were
purchased from Sigma-Aldrich (Saint Louis, MO,
USA). A Lactate Dehydrogenase (LDH) Reagent kit
was purchased from Jiancheng Bio-engineering Insti-
tute (Nanjing, China). HP-100 resin was purchased
from Mitsubishi Chemicals (Tokyo, Japan).
Preparation of ethanol extracts of TFFC
Ripe fruits of Guangzao (Fructus Choerospondiatis)
were collected in April 2010 from Baotou (Inner Mon-
golia, China). Extracts were obtained by refluxing the
dried, powdered fruit (2.7 kg) of Guangzao (Fructus
Choerospondiatis) with 50% ethanol for 60 min twice.
Resulting solutions were combined and filtered. After
solvent removal, fruit extracts were centrifuged. Super-
natants (12.6 L) were concentrated using a HPD100
macroporous resin for enrichment and then fractionat-
ed using water (0% ethanol) and increasing concentra-
tions of ethanol (20%, 50%, 70%, and 95%). The elu-
ates obtained with 50% ethanol were concentrated un-
der vacuum to produce a powder.
Analyses of constituents of fruit extracts using
high-performance liquid chromatography (HPLC)
Major constituents in active fractions of Guangzao
(Fructus Choerospondiatis) extracts were identified using
HPLC, which was undertaken using an Alltima™ C18
Reversed-phase Analytical Column and determination
of absorbance at 508 nm. Rutin was used as an exter-
nal standard. Finally, dry crude total flavonoids were
obtained (11.83 g) from fractions eluted in 50% etha-
nol. Total flavonoid content (53.65%) was determined
by colorimetric means. Major constituents in the select-
ed active fractions of Guangzao (Fructus Choerospondia-
tis) extracts were identified using HPLC coupled with
ultraviolet (UV) and ion trap liquid chromatogra-
phy-mass spectrometry (Esquire 3000 Plus ™; Bruker,
Billerica, MA, USA). Identified constituents were quan-
tified using an HP1100 series HPLC system compris-
ing a gradient pump and a Hypersil BDS-C18 5-μm
(250 mm × 4.6 mm) column (Agilent Technologies,
Santa Clara, CA, USA) maintained at ambient room
temperature. Gradient elution was done using the fol-
lowing mobile phase: water∶formic acid (100∶0.1, %
v/v) as solvent A and acetonitrile∶formic acid (100∶
0.1, % v/v) as solvent B. A gradient of 2%-30% sol-
vent B over 60 min was used, and the flow rate was
1.0 mL/min. For quantification, absorbance at 254 nm
was determined.
Cell culture
Cardiac fibroblasts were isolated from 3-day-old SD
rats using a differential attachment method reported
previously.5,6 Cells from the second to third passage
were used for all experiments. Cardiac fibroblasts were
distinguished from other cell types through immuno-
histochemical staining. Cardiac fibroblasts stained posi-
tive for the fibroblast marker fibronectin and stained
negative for a marker of muscle cells (α-actin).
Effect of TFFC on growth of cardiac fibroblasts
For culture of adherent cells, 500 μL of a suspension of
cardiac fibroblasts (2.0 × 104 cells/mL) was added to
each well of 24-well plates, and cells cultured in Dul-
becco's modified Eagle's medium (DMEM) containing
10% fetal calf serum (FCS) for 24 h. Adherent cells
were serum-starved for 24 h and then treated with vari-
ous concentrations of TFFC (0, 25, 50, 100 mg/mL)
in DMEM containing 0.2% FCS for 24, 48, and 72 h.
At each time point, cells were digested using 0.25% tryp-
sin for 6-8 min at 37℃ , stained with 0.4% trypan blue,
and the number of viable cells calculated using a hemo-
cytometer. Each experiment was done in triplicate.
Effect of TFFC on the AngⅡ-induced proliferation
of cardiac fibroblasts
Cell proliferation was assessed by the MTT assay.7
Briefly, 200 μL of a suspension of cardiac fibroblasts
(2.5×104 cells/mL) was added to each well of 96-well
plates and cultured to obtain adherent cells. Then, cells
were cultured in DMEM containing 10% FCS for 24 h,
starved by serum deprivation for 24 h, and then treat-
ed with various concentrations of TFFC (0, 25, 50,
100 mg/mL) in DMEM containing 0.2% FCS for 24,
48, and 72 h. Ang Ⅱ (100 nM) was added to a set of
cultures from each treatment group 1 h before TFFC
treatment. MTT (20 μL of 5 mg/mL) was added to
each well, cells incubated for 4 h, the culture superna-
tant removed, and cells treated with 150 μL of dimeth-
yl sulfoxide (DMSO) for 10 min. Absorbance at 490 nm
was determined using a Microplate Spectrophotometer
(Bio-Rad, Model 680). The experiment was done in
triplicate.
Effects of L-NAME and ODQ on proliferation of
cardiac fibroblasts
A suspension of cardiac fibroblasts (200 μL; 2.5 × 104
cells/mL) was added to each well of 96-well plates and
cultured in DMEM containing 10% FCS for 24 h to
obtain adherent cells. Cells were then serum-starved
for 24 h and treated with various concentrations of
TFFC (0, 25, 50, 100 mg/mL) in DMEM containing
0.2% FCS for 72 h. L-NAME (100 μM) and ODQ
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(10 μM) with or without 100 nM Ang Ⅱ were added
to the culture 1 h before TFFC treatment. Then, MTT
(20 μL of 5 mg/mL) was added to each well and incu-
bated for 4 h, followed by removal of the culture super-
natant and treatment of cells with 150 μL of DMSO
for 10 min. Finally, absorbance at 490 nm was deter-
mined using a Microplate Spectrophotometer
(Bio-Rad, Model 680).
Effect of TFFC on LDH release
Cardiac fibroblasts were seeded at 2.5×104 cells/mL in
96-well plates and cultured in DMEM containing
10% FCS for 24 h. Cells were serum-starved overnight
in 0.1% FCS and then treated with various concentra-
tions of TFFC in DMEM containing 0.2% FCS. AngⅡ (100 nM) was added to a set of cultures from each
treatment group 1 h before treatment with TFFC. Af-
ter 24, 48, and 72 h of incubation, culture media were
collected and LDH activity assayed using a colorimet-
ric method described previously.8 LDH activity was es-
timated by determining changes in the absorbance of
pyruvic acid at 440 nm using a Spectrophotometer
(Bio-Rad, Model 680).
Data analyses
Data are the mean ± standard deviation ( xˉ ± s).
One-way analysis of variance followed by Bonferroni's
multiple comparison tests were employed using SPSS
v10.0 (Higher Education Press, Beijing, China). P <
0.05 was considered significant.
RESULTS
TFFC chromatogram
Samples were quantified using an HP1100 series
HPLC system maintained at 35℃ (Figure 1).
Effect of TFFC on growth of cardiac fibroblasts
The effect of TFFC on the growth of cardiac fibro-
blasts was determined using a hemocytometer. TFFC
significantly inhibited the growth of cardiac fibroblasts
at concentrations of 25, 50, and 100 mg/mL in a
dose-and time-dependent manner (all P value < 0.05
or 0.01 except for TFFC 25 mg at 24 h) (Table 1).
Effect of TFFC on AngⅡ-induced proliferation of
cardiac fibroblasts
Effects of TFFC on Ang Ⅱ-induced proliferation of
cardiac fibroblasts were examined by the MTT assay.
Cardiac fibroblasts treated with 100-nM Ang Ⅱ
showed greater proliferation than that in the control
group (P < 0.01) (Table 2). At 25, 50, and 100 mg/
mL, TFFC inhibited proliferation of cardiac fibroblasts
in a dose-and time-dependent manner. The time-
course experiment using 100 mg/mL of TFFC suggest-
ed that the maximal inhibitory effect of TFFC was ob-
served 72 h after treatment. These results suggested
that pretreatment with TFFC significantly inhibited
the growth of cardiac fibroblasts (all P < 0.05 or < 0.01
except for TFFC 25 mg at 24 h).
Effect of TFFC and L-NAME on AngⅡ-induced
proliferation of cardiac fibroblasts
Next, we determined the effect of L-NAME on the in-
hibitory activity of TFFC. As shown in Table 3, cardiac
fibroblasts pretreated with Ang Ⅱ and L-NAME
showed greater proliferation than those treated with
Ang Ⅱ alone (P < 0.01). Treatment with TFFC de-
creased the quantity of MTT detected. These results
suggested that the inhibitory effect of TFFC was
blocked (at least in part) by pretreatment with 100-μM
L-NAME.
Figure 1 HPLC-UV 254-nm chromatogram of ethanol extract produced from guangzao (Fructus Choerospondiatis)
HPLC: high-performance liquid chromatography; UV: ultraviolet.
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Group
TFFC 0 mg/mL
TFFC 25 mg/mL
TFFC 50 mg/mL
TFFC 100 mg/mL
n
4
4
4
4
24 h
4.1±0.3
3.6±0.4
2.8±0.5
2.7±0.6
48 h
5.6±0.7
4.5±0.4
3.6±0.5
3.1±0.5
72 h
6.2±0.6
4.2±0.4
3.2±0.6
2.7±0.5
Notes: growth of cardiac fibroblasts growth was analyzed using a hemocytometer. Proliferation of cardiac fibroblasts was monitored 24, 48,
and 72 h. After pretreatment with TFFC (25, 50, 100 mg/mL), cell growth was inhibited in a dose- and time-dependent manner. Treat-
ment values are the mean ± standard deviation (n = 4). TFFC: total flavonoids of Guangzao (Fructus Choerospondiatis).
Table 1 Effect of TFFC on the growth of cardiac fibroblasts (cells, xˉ ± s)
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TFFC and ODQ on cardiac fibroblasts proliferation
induced by AngⅡ
To determine whether the inhibitory action of TFFC
was affected by ODQ, we incubated cells with 100 nM
Ang Ⅱ, followed by exposure to TFFC and ODQ for
72 h. As shown in Table 3, pretreatment with Ang Ⅱ
and ODQ stimulated cardiac fibroblasts proliferation
compared with Ang Ⅱ group (P < 0.01). TFFC
(25-100 mg) decreased in MTT value. These results in-
dicated that the inhibitory effect of TFFC was partly
blocked by 10 μm ODQ.
Effect of TFFC on LDH release
To confirm that the inhibitory effects of TFFC on
the proliferation of cardiac fibroblasts were not a re-
sult of cytotoxicity, the activity of LDH (a biochemi-
cal marker of cellular damage) in the culture medi-
um of TFFC- and Ang Ⅱ-treated cells was assayed.
TFFC (25-100 mg) had no effect on LDH release
for ≤ 72 h (Table 4). However, the effect of longer
exposure to, and higher concentrations of, TFFC
were not tested.
DISCUSSION
The anti-proliferative effects of TFFC on cardiac fibro-
blasts treated with Ang Ⅱ were investigated. Based on
our results, the mechanism of TFFC action may corre-
late with activation of the nitric oxide-cyclic guanosine
monophosphate (NO-cGMP) signaling pathway.
We found that TFFC inhibited AngⅡ-induced prolif-
eration of cardiac fibroblasts at concentrations of 25,
50, and 100 mg/L in a dose- and time-dependent man-
ner. At the doses tested, TFFC did not significantly af-
fect cell detachment, and only a few dead cells were de-
tected in the trypan blue exclusion test (data not
shown). To verify that the effects of TFFC on cardiac fi-
broblasts were not a consequence of cytotoxicity, we as-
sayed LDH activity (a parameter of cytotoxicity) in the
supernatants of TFFC- (25-100 mg/L) and AngⅡ-treated cells. LDH activity in the supernatants of
treated and untreated cells remained unchanged. This
finding was consistent with observations under light
microscopy. Therefore, the anti-proliferative effects
were due mainly to inhibition of cell proliferation and
Group
TFFC 0 mg/mL
AngⅡ
AngⅡ+TFFC 25 mg/mL
AngⅡ+TFFC 50 mg/mL
AngⅡ+TFFC 100 mg/mL
AngⅡ+Valsartan 10 μmol/L
n
4
4
4
4
4
4
TFFC and L-NAME
0.76±0.05
1.16±0.05
1.33±0.06
1.24±0.07
1.09±0.06
0.94±0.07
TFFC and ODQ
0.80±0.05
1.02±0.09
1.34±0.07
1.24±0.05
1.01±0.07
0.92±0.07
Notes: both Ang Ⅱ and L-NAME stimulated cardiac fibroblasts proliferation. The inhibitory effect of TFFC was partly blocked by 100
μM L-NAME. Both Ang Ⅱ and ODQ stimulated cardiac fibroblasts proliferation. The inhibitory effect of TFFC was partly blocked by
10 μM ODQ. TFFC: total flavonoids of Guangzao (Fructus Choerospondiatis); L-NAME: NG-nitro-L-arginine methyl ester; ODQ: 1H-[1,
2,4] oxadiazolo [4,3-a] quinoxalin-1-one.
Table 3 Effects of TFFC and L-NAME, ODQ and TFFC on cardiac fibroblasts proliferation ( xˉ ± s)
Group
TFFC 0 mg/mL
AngⅡ
AngⅡ+TFFC 25 mg/mL
AngⅡ+TFFC 50 mg/mL
AngⅡ+TFFC 100 mg/mL
n
4
4
4
4
4
24 h
23.0±0.7
23.1±0.7a
23.2±1.1a
23.6±0.7a
24.1±0.8a
48 h
23.6±0.8
23.7±0.7a
23.8±1.2a
24.4±0.9a
24.7±1.4a
72 h
24.7±0.6
24.8±0.9a
24.9±0.9a
25.1±0.6a
26.0±0.8a
Notes: LDH activity was assessed using a colorimetric method. aP > 0.05; vs control group at same time points. TFFC (25-100 mg) and
100-nM AngⅡ had no effect on LDH release at 24 h to 72 h. AngⅡ: angiotensinⅡ; TFFC: total flavonoids of Guangzao (Fructus Cho-
erospondiatis); LDH: lactate dehydrogenase.
Table 4 LDH activity in the culture medium of cardiac fibroblasts (U/L, xˉ ± s)
Group
TFFC 0 mg/mL
AngⅡ
AngⅡ+TFFC 25 mg/mL
AngⅡ+TFFC 50 mg/mL
AngⅡ+TFFC 100 mg/mL
AngⅡ+Valsartan 10 μmol/L
n
4
4
4
4
4
4
24 h
0.48±0.07
0.85±0.04
0.70±0.07
0.62±0.05
0.52±0.05
0.50±0.07
48 h
0.62±0.07
1.01±0.06
0.85±0.04
0.74±0.07
0.69±0.09
0.62±0.09
72 h
0.78±0.07
1.14±0.07
0.96±0.04
0.88±0.06
0.80±0.07
0.78±0.07
Notes: final concentration of AngⅡ was 100 nM. The frequency of proliferation was monitored after 24, 48, and 72 h. TFFC: total flavo-
noids of Guangzao (Fructus Choerospondiatis).
Table 2 Cell proliferation of groups ( xˉ ± s)
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not due to direct cytotoxicity. Pretreatment with
L-NAME9 (an inhibitor of nitric oxide synthase
(NOS)) or ODQ10,11 (an inhibitor of soluble guanylate
cyclase (sGC)) blocked the inhibitory effects of TFFC.
Our previous report showed that TFFC increased lev-
els of NO and NOS in the culture medium and in-
creased intracellular levels of cGMP in cardiac fibro-
blasts.12 Therefore, we speculate that TFFC may exert
its inhibitory effects through activation of the
NO-cGMP signaling pathway.
This study had one main limitation. We did not inves-
tigate whether TFFC affected the production of NO
and cGMP. Further studies are needed to elucidate the
mechanism of TFFC activity in vivo.
We demonstrated that TFFC extracted from guangzao
directly inhibited Ang Ⅱ-induced proliferation of car-
diac fibroblasts. Our findings demonstrate that TFFC:
(a) may have important cardioprotective effects; (b) ad-
ministration to cardiac fibroblasts may serve as a novel
approach for the treatment of cardiac fibrosis.
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